{"id":"NCT00606489","sponsor":"Cumberland Pharmaceuticals","briefTitle":"Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Fever and Pain in Burn Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2009-05","completion":"2009-05","firstPosted":"2008-02-04","resultsPosted":"2011-08-11","lastUpdate":"2011-08-11"},"enrollment":61,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Burns"],"interventions":[{"type":"DRUG","name":"Caldolor","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"PLACEBO_COMPARATOR"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study of Caldolor administered to hospitalized adult and pediatric burn patients is to determine the efficacy of Caldolor on reducing fever when compared to placebo when administered every 6 hours for at least 24 hours.","primaryOutcome":{"measure":"Temperature","timeFrame":"0 to 24 hours","effectByArm":[{"arm":"Placebo (250 Milliliters Normal Saline)","deltaMin":18.29,"sd":2.2},{"arm":"800mg Intravenous Ibuprofen","deltaMin":12.21,"sd":1.7}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["United States","India"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":21},"commonTop":["Leukocytosis","Anemia","Hypotension","Tachypnoea","Hyperchloremia"]}}